20. November 2009 11:37
Nutrisystem, Inc., a leading developer of weight loss products and services, today announced its company-wide support for the recently launched Stop DiabetesSM movement from the American Diabetes Association. On the heels of the successful launch of Nutrisystem D, its program designed to help people with type 2 diabetes lose weight, Nutrisystem has implemented a $5.00 contribution for every person who shares their story on the American Diabetes Association’s Stop Diabetes website, up to $100,000 through December 31, 2009.
[More]
20. November 2009 11:10
Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy, according to a largest of its kind study in the November 15 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
[More]
20. November 2009 09:51
CVS/pharmacy kicks off its annual in store fundraiser for the sixth year to support the St. Jude Children's Research Hospital Thanks and Giving campaign, beginning this Sunday and running through December 12. CVS/pharmacy store colleagues will encourage customers to add $1 to their purchase at the register to support the lifesaving research of St. Jude, one of the world's premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases.
[More]
20. November 2009 09:28
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).
[More]
9de2aaf9-d1dc-42a8-8d75-d56e72072c7e|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Biotechnology, Cancer, Cell, Chemotherapy, Glioma, Kidney Cancer, Lymphoma, Melanoma, Oncology, Renal Cell Carcinoma, Vaccine
20. November 2009 09:18
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
[More]
85b72941-1acc-4d4b-b579-2fd76594d425|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Blood Pressure, Efavirenz, Erectile Dysfunction, Exercise, Headache, Heart Failure, Impotence, Low Blood Pressure, Nevirapine, Pfizer, Pulmonary Arterial Hypertension, Ritonavir, Stroke, Veno-Occlusive Disease, Vitamin K, Warfarin
20. November 2009 09:14
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
[More]
20. November 2009 09:08
POZEN Inc. announced today the start of enrollment for the phase 3 studies for PA32540. PA32540 is a fixed-dose combination of 325 mg of enteric coated aspirin and 40 mg of immediate release omeprazole, under investigation for use in the secondary prevention of heart attacks and strokes in patients at risk for associated gastric ulcers.
[More]
20. November 2009 09:02
Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company’s lead oncology product, Genasense® (oblimersen sodium) Injection, administered for the first time as a 1-hour high-dose intravenous (IV) infusion.
[More]
4860eda6-fe31-4d8b-a8a6-7cc875daf80d|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Abraxane, Apoptosis, Bone, Cancer, Cell, Chemotherapy, Dacarbazine, DNA, Docetaxel, Evolution, Melanoma, Neutropenia, Oncology, Paclitaxel, Skin Cancer, Temozolomide
20. November 2009 08:37
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.
[More]
f23b18ab-0bd0-4d21-ad99-95fb9aaafa02|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Anemia, Arthritis, Asthma, Biotechnology, Bone, Bone Mineral Density, Cancer, Cell, Gene Expression, Gerontology, Osteoporosis, Pfizer, Psoriasis, Rheumatoid Arthritis, Sexual Dysfunction, Testosterone
20. November 2009 05:41
The newly discovered Th22 cells are a previously unknown subset of T helper cells. T helper cells are white blood cells that help activate other immune cells when the body is infected by viruses or bacteria. At the same time they help the body to tolerate own tissue and to prevent or curb inflammation.
[More]
20. November 2009 05:40
Karen Sokolof Javitch is hoping that her new CD: STAR TRACKS - THE TRIBUTE ALBUM will encourage people to throw away their cigarettes! "It's worth a try," says Javitch, who decided to dedicate her CD to Patrick Swayze, who recently died of pancreatic cancer. "He was a 3-pack-a-day smoker, and never quit, even when he got sick." Her mother also died at age 56 (like Patrick) and she is sure cigarette smoking contributed to her death.
[More]
20. November 2009 05:36
The authorization committee of the German Research Foundation (DFG) has approved funding for a collaborative research center proposed by the University of Freiburg on the topic „Control of Cell Motility in Morphogenesis, Tumor Invasion, and Metastatic Spread" starting on 1 January 2010. The Freiburg SFB 850 will receive a total of 9.4 million euros in the next four years plus a 20 percent program allowance for indirect costs. In the case of success, the SFB 850 is eligible to receive funding for up to 12 years.
[More]
20. November 2009 05:32
Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level.
[More]
20. November 2009 05:00
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.
[More]
83b4f6bc-d647-4da4-a307-6824cf566729|0|.0
Posted in: Medical Condition News | Healthcare News
Tags: Ace Inhibitor, Anemia, Angina, Angiotensin, Atherosclerosis, Blood Pressure, Blood Transfusion, Blood Vessel, Cardiology, Cardiovascular Disease, Congenital Heart Defect, Dentistry, Diabetes, Diet, Education, Exercise, Health and Human Services, Heart Failure, Hospital, Metabolic Syndrome, Obesity, Physiology, Pollution, Sleep, Smoking, Stroke, Transplant, Ultrasound, Weight Loss
20. November 2009 05:00
The artificial lower limbs of double-amputee Olympic hopeful Oscar Pistorius give him a clear and major advantage over his competition, taking 10 seconds or more off what his 400-meter race time would be if his prosthesis behaved like intact limbs.
[More] 
Subscribe